Wordt geladen...
Prognostic Significance of Alterations in IDH Enzyme Isoforms in Patients With AML Treated With High Dose Cytarabine and Idarubicin
BACKGROUND: IDH1 and IDH2 gene mutations are novel, recurring molecular aberrations among patients with normal karyotype acute myeloid leukemia (AML). METHODS: Among 358 patients with AML treated on 4 protocols using high dose ara-C plus idarubicin induction, pre-treatment samples were available for...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2011
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4060157/ https://ncbi.nlm.nih.gov/pubmed/22020636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26580 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|